Psychedelics and business could make for a bad trip | Curio
News and insights read out for you.
10,000+ audio articles. 50+ world-leading publications.

All in 1 subscription.

Financial Times logo

Psychedelics and business could make for a bad trip

6 mins | Nov 25, 2022
story image

Investors are beginning to sober up on psychedelics. From magic mushrooms to LSD, a new generation of business-minded psychedelic enthusiasts has emerged. With billions of people struggling, Jemima Kelly discusses the unlikely partnership between altruism and profit. But could it be too good to be true?

Get unlimited access free for 7 days, then $6.67/month (billed annually)
Get started